New York, Bronx, New York Clinical Trials

A listing of New York, Bronx, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 354 clinical trials
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

This is a single-arm Phase II clinical trial assessing the clinical efficacy of prostate specific membrane antigen (PSMA) PET/MR guided MR-LINAC based SBRT-SIB with planned accrual of 50 patients.

metastasis
adenocarcinoma of prostate
adenocarcinoma
stereotactic body radiation therapy
hbed-cc
Weill Cornell Medicine
 (7.5 away) Contact site
  • 16 views
  • 19 Feb, 2024
  • 1 location
Self-Control in Bulimia Nervosa

This study examines the influence of acute fasting and eating on self-control in adult females with and without bulimia nervosa (BN). Specifically, the study team is investigating whether differences in behavior and brain activation in response to computer tasks after fasting and after eating a meal could help to explain …

fasting
MRI
bulimia
Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai
 (5.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of CC-98633 BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed and/or Refractory Multiple Myeloma

This is a Phase 1, multicenter, open-label study of CC-98633, BCMA-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in subjects with relapsed and/or refractory multiple myeloma. The study will consist of 2 parts: dose-escalation (Part A) and dose-expansion (Part B). The dose-escalation part (Part A) of the study is to …

bcma
pomalidomide
multiple myeloma
lenalidomide
proteasome inhibitor
Icahn School of Medicine at Mount Sinai
 (5.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations
Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer

The researchers are doing this study to find out whether the researchers can combine information provided by PET/MRI scans with information from tests on blood and tissue samples to develop a very detailed description (profile) of high-grade serous ovarian carcinoma (HGSOC), which could improve our ability to treat this disease. …

ovarian cancer
carcinoma
ovarian carcinoma
cancer
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

antiandrogen therapy
testosterone
adenocarcinoma of prostate
darolutamide
luteinizing hormone
Memorial Sloan-Kettering Cancer Center
 (7.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors

This research study is studying a new drug, NC410, as a possible treatment for advanced or metastatic solid tumors.

systemic therapy
metastasis
hysterectomy
serum pregnancy test
measurable disease
John Theurer Cancer Center at Hackensack University Medical Center
 (10.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
ctgov trial 2

    dddd

Test Site
 (9.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

monoclonal protein
cell transplantation
immunotherapeutic agent
proteasome inhibitor
autologous hematopoietic stem cell transplant
Investigational Site Number 8400001
 (5.5 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +7 other locations
Sandeep 03821 testing  

Testing by Sandeep 

Online studies
Accepts healthy volunteers
cancer
Sandeep 03821
 (10.0 away)
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Study researchers think that a drug called enasidenib may help people with clonal cytopenia of undetermined significance (CCUS) because the drug blocks the mutated IDH2 protein, which may improve blood cell counts. The purpose of this study is to find out whether enasidenib is a safe and effective treatment for …

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (7.5 away) Contact site
  • 0 views
  • 02 Dec, 2024
  • +6 other locations